A team of Memorial Sloan Kettering Cancer Center (MSK) researchers have made an important finding about why genetically engineered immune cells sometimes fail to finish the job when given as a cancer ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する